Madde Kullanım Bozukluklarının Önlenmesi ve Erken Müdahalede Ebelik Bakımı
References
Geraghty S, Doleman G, De Leo A. Midwives’ attitudes towards pregnant women using substances: Informing a care pathway. Women and Birth, 2019;32(4): e477-e482. doi: 10.1016/j.wombi.2018.09.007
WHO, UNODC. International standards for the treatment of drug use disorders Revised with field test results. [Online] https://syntheticdrugs.unodc.org/uploads/syntheticdrugs/res/library/treatment_html/International_Standards_for_the_Treatment_of_Drug_Use_Disorders_Joint_WHO_UNODC_RU.pdf [Erişim Tarihi: 2 Temmuz 2024]
Roper V, Cox KJ. Opioid use disorder in pregnancy. Journal of Midwifery & Women’s Health, 2017;62(3): 329-340. doi: 10.1111/jmwh.12619
Rizk AH, Simonsen SE, Roberts L, et al. Maternity care for pregnant women with opioid use disorder: A review. Journal of Midwifery & Women’s Health, 2019;64(5): 532-544. doi: 10.1111/jmwh.13019
WHO. Optimizing the contributions of the nursing and midwifery workforce to achieve universal health coverage and the Sustainable Development Goals through education, research and practice. [Online] https://www.who.int/publications/i/item/9789241511971 [Erişim Tarihi: 2 Temmuz 2024]
Savage CL, Daniels J, Johnson JA, et al. The inclusion of substance use-related content in advanced practice registered nurse curricula. Journal of Professional Nursing, 2018;34(3): 217-220. doi: 10.1016/j.profnurs.2017.08.006
Muzyk A, Smothers ZPW, Andolsek KM, et al. Interprofessional substance use disorder education in health professions education programs: A scoping review. Academic Medicine, 2020;95(3): 470-480. doi: 10.1097/ACM.0000000000003053
Krans EE, Campopiano M, Cleveland LM, et al. National partnership for maternal safety: Consensus bundle on obstetric care for women with opioid use disorder. Obstetrics and Gynecology, 2019;134(2): 365-375. doi: 10.1097/AOG.0000000000003381
Ecker J, Abuhamad A, Hill W, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Society for Maternal Fetal Medicine Special Report, 2019;221(1): B5-B28. doi: 10.1016/j.ajog.2019.03.022
Goodman DJ, Saunders EC, Wolff KB. In their own words: A qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy and Childbirth, 2020;20(1): 1-10. doi: 10.1186/s12884-020-02872-5
Khazaee-Pool M, Pashaei T, Nouri R, et al. Understanding the relapse process: exploring Iranian women’s substance use experiences. Substance Abuse Treatment, Prevention and Policy, 2019;14(27): 1-11. doi: 10.1186/s13011-019-0216-3
Marchand K, Beaumont S, Westfall J, et al. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Substance Abuse Treatment, Prevention and Policy, 2019;14(37): 1-15. doi: 10.1186/s13011-019-0227-0
Hines LA, Freeman TP, Gage SH, et al. Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry, 2020;77(10): 1044-1051. doi: 10.1001/jamapsychiatry.2020.1035
Bakhireva LN, Shrestha S, Garrison L, et al. Prevalence of alcohol use in pregnant women with substance use disorder. Drug and Alcohol Dependence, 2018;187: 305-310. doi: 10.1016/j.drugalcdep.2018.02.025
Petersen Williams P, Mathews C, Jordaan E, et al. Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa. Clinical Ethics, 2020;15(4): 1-6. doi: 10.1177/1477750920928885
Phillippi JC, Schulte R, Bonnet K, et al. Reproductive-age women's experience of accessing treatment for opioid use disorder: "We don't do that here". Women’s Health Issues, 2021;31(5): 455-461. doi: 10.1016/j.whi.2021.03.010
Higgins TM, Goodman DJ, Meyer MC. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities. Preventine Medicine, 2019;128: 105786. doi: 10.1016/j.ypmed.2019.105786
Oni HT, Buultjens M, Abdel-Latif ME, et al. Barriers to screening pregnant women for alcohol or other drugs: A narrative synthesis. Women and Birth, 2019;32: 479-486. doi: 10.1016/j.wombi.2018.11.009
Shogren MD, Harsell C, Heitkamp T. Screening women for at-risk alcohol use: An introduction to screening, brief intervention and referral to treatment (SBIRT) in women’s health. Journal of Midwifery & Women’s Health, 2017;62(6): 746-754. doi: 10.1111/jmwh.12659
Patrick SW, Schiff DM, Committee on Substance Use and Prevention. A public health response to opioid use in pregnancy. Pediatrics, 2017;139(3): e20164070. doi: 10.1542/peds.2016-4070
Tosin Oni H, Buultjens M, Blandthorn J, et al. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: A qualitative study of midwives’ experience. Midwifery, 2020;81: 102595. doi: 10.1016/j.midw.2019.102595
Byatt N, Masters GA, Bergman AL, et al. Screening for mental health and substance use disorders in obstetric settings. Current Psychiatry Reports, 2020;22(11): 1-13. doi: 10.1007/s11920-020-01182-z
McDonald LR, Antoine DG, Liao C, et al. Syndemic of lifetime mental illness, substance use disorders, and trauma and their association with adverse perinatal outcomes. Journal of Interpersonal Violence, 2020;35(1-2): 476-495. doi: 10.1177/0886260516685708.
Dozet D, Burd L, Popova S. Screening for alcohol use in pregnancy: a Review of current practices and perspectives. International Jorunal of Mental Health and Addiction, 2023;21(2): 1220-1239. doi: 10.1007/s11469-021-00655-3
Petersen Williams P, Mathews C, Jordaan E, et al. Predictors of alcohol use during pregnancy among women attending midwife obstetric units in the Cape Metropole, South Africa. Substance Use & Misuse. 2018;53(8): 1342-1352. doi: 10.1080/10826084.2017.1408654
Sutter MB, Watson H, Bauers A, et al. Group prenatal care for women receiving medication-assisted treatment for opioid use disorder in pregnancy: An interprofessional approach. Journal of Midwifery & Women’s Health, 2019;64(2): 217-224. doi: 10.1111/jmwh.12960
Kramlich D, Kronk R, Marcellus L, et al. Rural postpartum women with substance use disorders. Qualitative Health Research, 2018;28(9): 1449-1461. doi: 10.1177/1049732318765720
Coates D, Foureur M. The role and competence of midwives in supporting women with mental health concerns during the perinatal period: A scoping review. Health & Social Care in the Community, 2019;27(4): e389-e405. doi: 10.1111/hsc.12740
O’Rourke-Suchoff D, Sobel L, Holland E, et al. The labor and birth experience of women with opioid use disorder: A qualitative study. Women and Birth, 2020;33: 592-597. doi: 10.1016/j.wombi.2020.01.006
Clemans-Cope L, Lynch V, Howell E, et al. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013–2016. Drug and Alcohol Dependence, 2019;195: 156-163. doi: 10.1016/j.drugalcdep.2018.12.005
Bielenberg J, Swisher G, Lembke A, et al. A systematic review of stigma interventions for providers who treat patients with substance use disorders. Journal of Substance Abuse Treatment, 2021;131: 108486. doi: 10.1016/j.jsat.2021.108486
Wouldes TA, Crawford A, Stevens S, et al. Evidence for the effectiveness and acceptability of e-SBI or e-SBIRT in the management of alcohol and illicit substance use in pregnant and post-partum women. Frontiers in Psychiatry, 2021;12: 1-15. doi: 10.3389/fpsyt.2021.634805
Zhao L, McCauley K, Sheeran L. The interaction of pregnancy, substance use and mental illness on birthing outcomes in Australia. Midwifery, 2017;54: 81-88. doi: 10.1016/j.midw.2017.08.007
Proulx D, Fantasia HC. The lived experience of postpartum women attending outpatient substance treatment for opioid or heroin use. Journal of Midwifery & Women’s Health, 2021;66(2): 211-217. doi: 10.1111/jmwh.13165
Barnett ER, Knight E, Herman RJ, et al. Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders. Journal of Substance Abuse Treatment, 2021;126: 108341. doi: 10.1016/j.jsat.2021.108341
Hafekost K, Lawrence D, O’Leary, et al. Maternal alcohol use disorder and subsequent child protection contact: A record-linkage population cohort study. Child Abuse & Neglect, 2017a;72: 206-214. doi: 10.1016/j.chiabu.2017.08.010
Goodman DJ, Saunders EC, Frew JR, et al. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study. American Journal of Obstetrics & Gynecology, 2022;4(1): 100489. doi: 10.1016/j.ajogmf.2021.100489
Reid N, Gamble J, Creedy DK, et al. Benefits of caseload midwifery to prevent fetal alcohol spectrum disorder: A discussion paper. Women and Birth, 2019;32: 3-5. doi: 10.1016/j.wombi.2018.03.002
Chiodo LM, Cosmian C, Pereira K, et al. Prenatal alcohol screening during pregnancy by midwives and nurses. Alcoholism: Clinical and Experimental Research, 2019;43(8): 1747-1758. doi: 10.1111/acer.14114
Erng MN, Smirnov A, Reid N. Prevention of alcohol-exposed pregnancies and fetal alcohol spectrum disorder among pregnant and postpartum women: A systematic review. Alcoholism: Clinical and Experimental Research, 2020;44(12): 2431-2448. doi: 10.1111/acer.14489
Rutman D, Hubberstey C, Poole N, et al. Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients' perspectives on wraparound programming. BMC Pregnancy and Childbirth, 2020;20(1): 1-14. doi: 10.1186/s12884-020-03109-1
Rayment-Jones H, Silverio SA, Harris J, et al. Project 20: Midwives’ insight into continuity of care models for women with social risk factors: what works, for whom, in what circumstances, and how. Midwifery, 2020;84: 102654. doi: 10.1016/j.midw.2020.102654
WHO, UNODC. International standards for the treatment of drug use disorders Revised with field test results. [Online] https://syntheticdrugs.unodc.org/uploads/syntheticdrugs/res/library/treatment_html/International_Standards_for_the_Treatment_of_Drug_Use_Disorders_Joint_WHO_UNODC_RU.pdf [Erişim Tarihi: 2 Temmuz 2024]
Roper V, Cox KJ. Opioid use disorder in pregnancy. Journal of Midwifery & Women’s Health, 2017;62(3): 329-340. doi: 10.1111/jmwh.12619
Rizk AH, Simonsen SE, Roberts L, et al. Maternity care for pregnant women with opioid use disorder: A review. Journal of Midwifery & Women’s Health, 2019;64(5): 532-544. doi: 10.1111/jmwh.13019
WHO. Optimizing the contributions of the nursing and midwifery workforce to achieve universal health coverage and the Sustainable Development Goals through education, research and practice. [Online] https://www.who.int/publications/i/item/9789241511971 [Erişim Tarihi: 2 Temmuz 2024]
Savage CL, Daniels J, Johnson JA, et al. The inclusion of substance use-related content in advanced practice registered nurse curricula. Journal of Professional Nursing, 2018;34(3): 217-220. doi: 10.1016/j.profnurs.2017.08.006
Muzyk A, Smothers ZPW, Andolsek KM, et al. Interprofessional substance use disorder education in health professions education programs: A scoping review. Academic Medicine, 2020;95(3): 470-480. doi: 10.1097/ACM.0000000000003053
Krans EE, Campopiano M, Cleveland LM, et al. National partnership for maternal safety: Consensus bundle on obstetric care for women with opioid use disorder. Obstetrics and Gynecology, 2019;134(2): 365-375. doi: 10.1097/AOG.0000000000003381
Ecker J, Abuhamad A, Hill W, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Society for Maternal Fetal Medicine Special Report, 2019;221(1): B5-B28. doi: 10.1016/j.ajog.2019.03.022
Goodman DJ, Saunders EC, Wolff KB. In their own words: A qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders. BMC Pregnancy and Childbirth, 2020;20(1): 1-10. doi: 10.1186/s12884-020-02872-5
Khazaee-Pool M, Pashaei T, Nouri R, et al. Understanding the relapse process: exploring Iranian women’s substance use experiences. Substance Abuse Treatment, Prevention and Policy, 2019;14(27): 1-11. doi: 10.1186/s13011-019-0216-3
Marchand K, Beaumont S, Westfall J, et al. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Substance Abuse Treatment, Prevention and Policy, 2019;14(37): 1-15. doi: 10.1186/s13011-019-0227-0
Hines LA, Freeman TP, Gage SH, et al. Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiatry, 2020;77(10): 1044-1051. doi: 10.1001/jamapsychiatry.2020.1035
Bakhireva LN, Shrestha S, Garrison L, et al. Prevalence of alcohol use in pregnant women with substance use disorder. Drug and Alcohol Dependence, 2018;187: 305-310. doi: 10.1016/j.drugalcdep.2018.02.025
Petersen Williams P, Mathews C, Jordaan E, et al. Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa. Clinical Ethics, 2020;15(4): 1-6. doi: 10.1177/1477750920928885
Phillippi JC, Schulte R, Bonnet K, et al. Reproductive-age women's experience of accessing treatment for opioid use disorder: "We don't do that here". Women’s Health Issues, 2021;31(5): 455-461. doi: 10.1016/j.whi.2021.03.010
Higgins TM, Goodman DJ, Meyer MC. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities. Preventine Medicine, 2019;128: 105786. doi: 10.1016/j.ypmed.2019.105786
Oni HT, Buultjens M, Abdel-Latif ME, et al. Barriers to screening pregnant women for alcohol or other drugs: A narrative synthesis. Women and Birth, 2019;32: 479-486. doi: 10.1016/j.wombi.2018.11.009
Shogren MD, Harsell C, Heitkamp T. Screening women for at-risk alcohol use: An introduction to screening, brief intervention and referral to treatment (SBIRT) in women’s health. Journal of Midwifery & Women’s Health, 2017;62(6): 746-754. doi: 10.1111/jmwh.12659
Patrick SW, Schiff DM, Committee on Substance Use and Prevention. A public health response to opioid use in pregnancy. Pediatrics, 2017;139(3): e20164070. doi: 10.1542/peds.2016-4070
Tosin Oni H, Buultjens M, Blandthorn J, et al. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: A qualitative study of midwives’ experience. Midwifery, 2020;81: 102595. doi: 10.1016/j.midw.2019.102595
Byatt N, Masters GA, Bergman AL, et al. Screening for mental health and substance use disorders in obstetric settings. Current Psychiatry Reports, 2020;22(11): 1-13. doi: 10.1007/s11920-020-01182-z
McDonald LR, Antoine DG, Liao C, et al. Syndemic of lifetime mental illness, substance use disorders, and trauma and their association with adverse perinatal outcomes. Journal of Interpersonal Violence, 2020;35(1-2): 476-495. doi: 10.1177/0886260516685708.
Dozet D, Burd L, Popova S. Screening for alcohol use in pregnancy: a Review of current practices and perspectives. International Jorunal of Mental Health and Addiction, 2023;21(2): 1220-1239. doi: 10.1007/s11469-021-00655-3
Petersen Williams P, Mathews C, Jordaan E, et al. Predictors of alcohol use during pregnancy among women attending midwife obstetric units in the Cape Metropole, South Africa. Substance Use & Misuse. 2018;53(8): 1342-1352. doi: 10.1080/10826084.2017.1408654
Sutter MB, Watson H, Bauers A, et al. Group prenatal care for women receiving medication-assisted treatment for opioid use disorder in pregnancy: An interprofessional approach. Journal of Midwifery & Women’s Health, 2019;64(2): 217-224. doi: 10.1111/jmwh.12960
Kramlich D, Kronk R, Marcellus L, et al. Rural postpartum women with substance use disorders. Qualitative Health Research, 2018;28(9): 1449-1461. doi: 10.1177/1049732318765720
Coates D, Foureur M. The role and competence of midwives in supporting women with mental health concerns during the perinatal period: A scoping review. Health & Social Care in the Community, 2019;27(4): e389-e405. doi: 10.1111/hsc.12740
O’Rourke-Suchoff D, Sobel L, Holland E, et al. The labor and birth experience of women with opioid use disorder: A qualitative study. Women and Birth, 2020;33: 592-597. doi: 10.1016/j.wombi.2020.01.006
Clemans-Cope L, Lynch V, Howell E, et al. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013–2016. Drug and Alcohol Dependence, 2019;195: 156-163. doi: 10.1016/j.drugalcdep.2018.12.005
Bielenberg J, Swisher G, Lembke A, et al. A systematic review of stigma interventions for providers who treat patients with substance use disorders. Journal of Substance Abuse Treatment, 2021;131: 108486. doi: 10.1016/j.jsat.2021.108486
Wouldes TA, Crawford A, Stevens S, et al. Evidence for the effectiveness and acceptability of e-SBI or e-SBIRT in the management of alcohol and illicit substance use in pregnant and post-partum women. Frontiers in Psychiatry, 2021;12: 1-15. doi: 10.3389/fpsyt.2021.634805
Zhao L, McCauley K, Sheeran L. The interaction of pregnancy, substance use and mental illness on birthing outcomes in Australia. Midwifery, 2017;54: 81-88. doi: 10.1016/j.midw.2017.08.007
Proulx D, Fantasia HC. The lived experience of postpartum women attending outpatient substance treatment for opioid or heroin use. Journal of Midwifery & Women’s Health, 2021;66(2): 211-217. doi: 10.1111/jmwh.13165
Barnett ER, Knight E, Herman RJ, et al. Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders. Journal of Substance Abuse Treatment, 2021;126: 108341. doi: 10.1016/j.jsat.2021.108341
Hafekost K, Lawrence D, O’Leary, et al. Maternal alcohol use disorder and subsequent child protection contact: A record-linkage population cohort study. Child Abuse & Neglect, 2017a;72: 206-214. doi: 10.1016/j.chiabu.2017.08.010
Goodman DJ, Saunders EC, Frew JR, et al. Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study. American Journal of Obstetrics & Gynecology, 2022;4(1): 100489. doi: 10.1016/j.ajogmf.2021.100489
Reid N, Gamble J, Creedy DK, et al. Benefits of caseload midwifery to prevent fetal alcohol spectrum disorder: A discussion paper. Women and Birth, 2019;32: 3-5. doi: 10.1016/j.wombi.2018.03.002
Chiodo LM, Cosmian C, Pereira K, et al. Prenatal alcohol screening during pregnancy by midwives and nurses. Alcoholism: Clinical and Experimental Research, 2019;43(8): 1747-1758. doi: 10.1111/acer.14114
Erng MN, Smirnov A, Reid N. Prevention of alcohol-exposed pregnancies and fetal alcohol spectrum disorder among pregnant and postpartum women: A systematic review. Alcoholism: Clinical and Experimental Research, 2020;44(12): 2431-2448. doi: 10.1111/acer.14489
Rutman D, Hubberstey C, Poole N, et al. Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients' perspectives on wraparound programming. BMC Pregnancy and Childbirth, 2020;20(1): 1-14. doi: 10.1186/s12884-020-03109-1
Rayment-Jones H, Silverio SA, Harris J, et al. Project 20: Midwives’ insight into continuity of care models for women with social risk factors: what works, for whom, in what circumstances, and how. Midwifery, 2020;84: 102654. doi: 10.1016/j.midw.2020.102654
Pages
353-372
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
